Genovior Biotech Corp.

Miaoli County, 
  • Booth: 1715

Genovior is a dedicated CDMO focusing on process development, scale up technology, formulation development, and productivity optimization under cGMP and PIC/S for our customers worldwide. Our one-stop services conveniently provide effective and efficient solution and our non-competition policy provides maximum security and protection in IP for our clients.

With support of experienced team, our services/ products incorporate APIs and injectables covering small molecule, oncology and biologics. More than 30 self-owned projects of generic and biosimilar drugs are under development and some are ready for out-licensing.


  • Injectable Available for Licensing
    Oncology, Peptide, Biologic, Others...

  • Injectable Available for Licensing
  • CDMO/CMO 2

  • Genovior is capably of developing protein process for the products, either new or generic biologics, initiated by clients for clinical application or for filing purposes for commercial productions in a timely fashion and under economical budgeting. Genovior can also efficiently and effectively tech-transfer microbial process, both up-stream and down-stream to our facilities from customers.

    Genovior provides high quality services for finished products of vials in liquid or lyophilized forms, prefilled syringe, cartridge, and dual chamber syringe/cartridge. PIC/S or US FDA guidelines are strictly followed in our facilities. We can also provide services for development of lyophilization program as well as design of packaging box, labeling of randomized code and labels, and packing of the final product.

  • CDMO/CMO 3
    Biologic, Oncology...

  • Genovior offers contract manufactures for biologics in scales ranging from preclinical, clinical, to commercial uses.  Our expertise and capabilities in upstream fermentation, downstream purification, and lyophilization provide wide range of services for our clients worldwide.

    Genovior’s dedicated oncology line includes sterile lyophilization and liquid for injection, and available from pilot to commercial scale. Based on project management, we offer full-service from API to finished dosage form of injectable products.

  • CDMO/CMO 1
    PFS, Lyophilization...

  • Genovior provides full chemistry, manufacturing and controls (CMC) services for drug candidates. We have the experience and expertise in the development of small molecules, polypeptide and proteins for parenteral injectable formulation includes liquid solutions, suspensions, liposome and lyophilized products, etc. Especially, we can formulate a long-acting release delivery systems of PEGylation technology, microsphere, nanoparticles, micellar, nano-carrier and liposome. All formulations by Genovior can be scaled up in order to manufacture cGMP drugs for uses in clinical trials and commercialization. Genovior formulation development services include:
  • CDMO/CMO 4
    Genovior Biotech Corp. (GBC) is a vertically integrated contract manufacturing company (CMO), providing following services....

  • Genovior Biotech Corp. (GBC) is a vertically integrated contract manufacturing company (CMO), providing following services:
    • process development of peptide or protein APIs from microbial or human recombinant fermentation processes
    • formulation development of biological injectables
    • manufacturing capacities of biological APIs, lyophilized injectables, and prefilled syringe/cartridge for preclinical, clinical, and commercial uses